The FY24 Defense Appropriations Act provides funding for the Glioblastoma Research Program to support high impact research to reduce the burden of glioblastoma on service members and their families, veterans, and the American public.
David B. Weiner, of the Wistar Institute, and his laboratory, created a new therapeutic design for glioblastoma, the deadliest form of brain cancer.
